Movatterモバイル変換


[0]ホーム

URL:


EP2084634A2 - System and method for diabetes management using consumer electronic devices - Google Patents

System and method for diabetes management using consumer electronic devices

Info

Publication number
EP2084634A2
EP2084634A2EP07868762AEP07868762AEP2084634A2EP 2084634 A2EP2084634 A2EP 2084634A2EP 07868762 AEP07868762 AEP 07868762AEP 07868762 AEP07868762 AEP 07868762AEP 2084634 A2EP2084634 A2EP 2084634A2
Authority
EP
European Patent Office
Prior art keywords
consumer electronic
electronic device
connector
medical device
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP07868762A
Other languages
German (de)
French (fr)
Inventor
Himanshu Patel
Emil Istoc
Jack Lin
Ajit Narang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Minimed Inc
Original Assignee
Medtronic Minimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Minimed IncfiledCriticalMedtronic Minimed Inc
Priority to EP11177237ApriorityCriticalpatent/EP2386971A3/en
Publication of EP2084634A2publicationCriticalpatent/EP2084634A2/en
Ceasedlegal-statusCriticalCurrent

Links

Classifications

Definitions

Landscapes

Abstract

The invention is embodied in a system for diabetes management including a medical device (MD) and a consumer electronic device (CED). The CED may be used to monitor and control the MD. The system includes a connector that plugs into the CED to allow communication between the MD and the CED. The medical device may be an external infusion device, implantable pump, glucose meter, glucose monitor, continuous glucose monitoring system, or the like. The CED may be any type of consumer electronic device including, but not limited to, cellular phones, personal digital assistants (PDAs), BlackBerry, Smartphones, pocketpc phones, mp3 players, radios, CD players, and the like.

Description

TITLE
[0001] Systems and Methods for Diabetes Management Using Consumer Electronic Devices
RELATED APPLICATIONS
[0002] This application claims the benefit of prior filed U.S. Provisional Application Serial
No. 60/866,409, filed on November 17, 2006.
FIELD OF THE INVENTION
[0003] Embodiments of the invention relate to diabetes management systems and, more particularly, to managing diabetes utilizing consumer electronic devices including cellular phones, MP3/digital audio players, personal digital assistants (PDAs), Smartphones, hybrid devices, and the like.
BACKGROUND OF THE INVENTION
[0004] Infusion devices and glucose monitoring systems are relatively well known in the medial arts, particularly for use monitoring blood glucose levels and delivering or dispensing a prescribed medication to a user. In many cases, the user suffers from diabetes — a disease in which the body does not produce or properly use insulin. Approximately 13 million people in the United States have been diagnosed with some form of diabetes. Type 1 diabetes results from the body's failure to produce insulin. Type 2 diabetes results from insulin resistance in which the body fails to properly use insulin. In order to effectively manage and/or control the disease, diabetics must closely monitor and manage their blood glucose levels through exercise, diet and medications in addition to supplying their body with appropriate amounts of insulin based on daily routines. In particular, both Type 1 and Type 2 diabetics rely on insulin delivery and blood glucose monitoring systems to control diabetes. [0005] External infusion devices have been used to deliver medication to a patient as generally described in U.S. Patent Nos. 4,562,751; 4,678,408; 4,685,903; 6,554,798, and 6,551,276 which are specifically incorporated by reference herein. In recent years, continuous glucose monitoring systems have been developed utilizing the latest sensor technologies incorporating both implantable and external sensors, as generally described in U.S. Pat. No. 5,391,250 entitled "Method of Fabricating Thin Film Sensors", U.S. Pat. No. 6,484,046 entitled "Electrochemical Analyte Sensor," and U.S. Pat. Nos. 5,390,671, 5,568,806 and 5,586,553, entitled "Transcutaneous Sensor Insertion Set," all of which are specifically incorporated by reference herein. Newer systems deliver the preciseness of finger stick measurements coupled with the convenience of not having to repeatedly prick the skin to obtain glucose measurements. These newer systems provide the equivalent of over 200 finger stick readings per day. Additionally, continuous glucose monitoring systems allow physicians and patients to monitor blood glucose trends of their body and suggest and deliver insulin based on each patient's particular needs. Accordingly, physicians and medical device companies are always searching for more convenient ways to keep diabetic patients aware of their blood glucose levels throughout the day.
[0006] Diabetic patients utilizing infusion therapy and continuous glucose monitoring systems depend on extremely precise and accurate systems to assure appropriate blood glucose readings and insulin delivery amounts. However, utilizing these forms of therapy requires the user to carry multiple medical devices containing intricate circuitry and processing capabilities. Although today's infusion devices and glucose monitoring systems are indeed compact, there remains a need in the art for more compact and/or converged systems to manage diabetes, such that the user's life style and mobility are not restricted.
SUMMARY OF THE DISCLOSURE
[0007] According to an embodiment of the invention, a system is for managing diabetes using a consumer electronic device, including a medical device for taking a physiological reading of a user. The medical device includes a transmitter for communicating the physiological readings. In addition, the system includes a consumer electronic device, which includes software for managing and processing data obtained by the medical device. The system also includes a connector removably coupled to the consumer electronic device for facilitating communication between the medical device and the consumer electronic device.
In some embodiments, the connector receives data from the medical device in a first communication protocol, and the connector transmits data to the consumer electronic device in a second communication protocol.
[0008] In other embodiments, the medical device is a continuous glucose monitoring system and/or an infusion device. In still additional embodiments, the consumer electronic device is a Smartphone. In still further embodiments, the consumer electronic device is an MP3 player. In some embodiments, the software on the consumer electronic device is a Java application.
[0009] In further embodiments, the Smartphone transmits the received data to a central server using an internet connection and/or transmits the received data to a different cellular phone using "Short Message Service" (commonly known as "SMS" or "text messaging"). In other embodiments, the Smartphone initiates a cellular phone call based on a particular event. In yet further embodiments, the software includes alarm capabilities to alert the user of a particular event. In other additional embodiments, the first communication protocol is a proprietary protocol maintained by the medical device manufacturer and the second communication protocol is Bluetooth.
[0010] According to another embodiment of the invention, a method is for managing diabetes using a consumer electronic device, including the steps of pairing a connector to a consumer electronic device. Next the consumer electronic device is programmed to communicate with a medical device for taking a physiological reading of a user, where the medical device is pre-programmed to communicate with the connector, allowing communication between the consumer electronic device and the medical device thorough the connector. Later, data is sent from the medical device to the consumer electronic device via the connector. The data is processed and displayed on the consumer electronic device. In some embodiments, the medical device is a continuous glucose monitoring system. In other embodiments, the consumer electronic device is a Smartphone.
[0011] According to a further embodiment of the invention, a system for providing information obtained from a medical device to an individual at a remote location is disclosed. The system includes a medical device for taking a physiological reading of a user, where the medical device includes a transmitter for communicating the physiological reading. The system also includes a local consumer electronic device, where the local consumer electronic device includes software for receiving, managing and processing data obtained by the medical device. A connector is also used by the system and the connector is removably coupled to the local consumer electronic device for facilitating communication between the medical device and the local consumer electronic device. Finally, a remote consumer electronic device is included for receiving information sent from the local consumer electronic device, where the connector receives data from the medical device in a first communication protocol, and the connector transmits data to the local consumer electronic device in a second communication protocol. In particular embodiments, the remote consumer electronic device receives information from the local consumer electronic device through a third communication protocol. In other embodiments, the first communication protocol is a proprietary protocol maintained by the medical device manufacturer, the second communication protocol is Bluetooth, and the third communication protocol is cellular communication. Still in additional embodiments, the cellular communication allows the local consumer electronic device to send information to the remote consumer electronic device using SMS, MMS, or email.
[0012] In yet another embodiment of the invention, a connector is for use with a consumer electronic device and a medical device. The connector includes a connecting structure for attaching the connector to the consumer electronic device and a power supply for providing power to the connector. The connector further includes a first communication protocol for transmitting data between the medical device and the connector and a second communication protocol for transmitting data between the connector and the consumer electronic device. In particular embodiments, the first communication protocol is a proprietary protocol maintained by a manufacturer of the medical device and the second communication protocol is Bluetooth.
[0013] According to another embodiment of the invention, a software-based application for receiving, managing and processing medical device data on a consumer electronic device is disclosed. In some embodiments, the software-based application includes a graphical user interface for displaying data to a patient, an input mechanism for use by the patient to adjust settings in the software-based application, and alarms for alerting and reminding the patient. [0014] Other features and advantages of the invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings which illustrate, by way of example, various features of embodiments of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
[0015] A detailed description of embodiments of the invention will be made with reference to the accompanying drawings, where like numerals designate corresponding parts or cross- sections in the several figures.
[0016] FIG. 1 is a simplified diagram of a diabetes management system including a PDA/Smartphone, a connector, and a glucose monitoring device in accordance with an embodiment of the present invention.
[0017] FIG. 2 shows perspective views of a PDA/Smartphone and connector in accordance with an embodiment of the present invention.
[0018] FIG. 3 is a simplified diagram of a diabetes management system including an MP3 player, a connector, and a glucose monitoring device in accordance with an embodiment of the present invention.
[0019] FIG. 4 shows perspective views of a PDA/Smartphone and connector in accordance with an embodiment of the present invention. [0020] FIG. 5 shows the graphical user interface of the medical device software running on the consumer electronic device (BlackBerry) in accordance with an embodiment of the present invention.
[0021] FIG. 6 is a flow diagram describing operation of the diabetes management system using a BlackBerry, a connector and a blood glucose monitoring system in accordance with an embodiment of the present invention.
[0022] FIG. 7 shows screenshots of the software's graphical user interface (including menus and graphs) running on the consumer electronic device in accordance with an embodiment of the present invention.
[0023] FIG. 8 shows screenshots of glucose threshold profiles and menus on the consumer electronic device in accordance with an embodiment of the present invention.
[0024] FIG. 9 shows screenshots of the menu structure for the "Meter BG" sub-menu in accordance with an embodiment of the present invention.
[0025] FIG. 10 shows screenshots of the menu structure for the "Alarm History" sub-menu in accordance with an embodiment of the present invention.
[0026] FIG. 11 shows screenshots of the menu structure for the "Alerts" sub-menu in accordance with an embodiment of the present invention.
[0027] FIG. 12 shows screenshots of the menu structure for the "Sensor" sub-menu in accordance with an embodiment of the present invention.
[0028] FIG. 13 shows screenshots of the menu structure for the "Events" sub-menu in accordance with an embodiment of the present invention.
[0029] FIG. 14 shows screenshots of the software's indication profile menu in accordance with an embodiment of the present invention.
[0030] FIG. 15 shows a screenshot of a sample hypoglycemic alarm issued in the software running on the consumer electronic device in accordance with an embodiment of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS [0031] As shown in the drawings for purposes of illustration, the invention is embodied in a system for diabetes management including a medical device (MD) and a consumer electronic device (CED). The CED may be used to monitor and/or control the MD. In particular embodiments, the system may include a connector that plugs into the CED to allow communication between the MD and the CED. The medical device may be an external infusion device, implantable pump, glucose meter, glucose monitor, continuous glucose monitoring system, or the like. The CED may be any type of consumer electronic device including, but not limited to, cellular phones, personal digital assistants (PDAs), BlackBerry, Smartphones, pocketpc phones, mp3 players, radios, CD players, and the like. The CED may run its own proprietary operating system and would be capable of running a program to communicate and/or interact with the MD. The program may be Java based, web-based, contained on a digital memory card (SD, compact flash, microSD, or the like), and/or bundled on a CD-ROM with the MD. In particular embodiments, the program may work on multiple operating systems used on CEDs including, but not limited to, BlackBerry OS, Windows Mobile, Palm OS, .NET framework, Symbian, iPod OS, iPhone OS, Zune OS, and the like. Communication between the CED and the MD may be established using a connector that attaches to the CED. The connector would receive communication from the MD and relay that communication to the CED via a hard wired or wireless connection. [0032] In particular embodiments, the connector may plug into an available port (i.e., mini- USB) on the CED (BlackBerry) and the connector may communicate with the BlackBerry via the mini-USB port or via Bluetooth communication. In these particular embodiments, a Java program would run on the BlackBerry to receive and control data received from the MD. In some embodiments, the MD may be a glucose sensor/transmitter of the type described in U.S. Patent No. 5,391,250 entitled "Method of Fabricating Thin Film Sensors", U.S. Patent No. 6,484,046 entitled "Electrochemical Analyte Sensor," U.S. Patent Nos. 5,390,671, 5,568,806 and 5,586,553, entitled "Transcutaneous Sensor Insertion Set," U.S. Patent No. 6,809,653 entitled "Telemetered Characteristic Monitor System And Method Of Using The Same," and U.S. Patent Application Serial Nos. 09/377,472, 11/225,790, 11/225,296, 11/322,568 and entitled "Telemetered Characteristic Monitor System And Method Of Using The Same," all of which are specifically incorporated by reference herein. The glucose sensor/transmitter would be capable of sending data to the connector using proprietary communication between the connector and the glucose sensor/transmitter. The data would then be sent to the BlackBerry and manipulated using the Java based program. The data obtained by the CED can show graphs, glucose trends, highs, lows, etc. — all accomplished using the familiar CED interface the user is accustomed to working with.
[0033] In further embodiments, the program may include alarm capabilities using the hardware and software available on, for example, a BlackBerry. Additionally, the data received from the glucose sensor/transmitter may be communicated to other locations using the BlackBerry' s cellular capabilities. Data can be sent to other phones, central servers, and the like using "Short Message Service" (commonly known as "SMS" or "text messaging"). Data may also be sent to email addresses, other computers, and/or central servers using the BlackBerry's internet capabilities (GPRS, EDGE, EV-DO, IxRTT, UMTS/HSDPA, Wi-Fi, WiMax, ZigBee, Wi-bro, and the like). In addition, based on certain conditions, the data may also provoke the BlackBerry to initiate a telephone call to emergency services (i.e., 911), a caregiver's house, a cell phone number, a central management station, or the like. In further embodiments, the Java program may include pre-recorded messages to playback upon initiation of a cellular telephone call to alert the person or computer receiving the call that a particular condition has been met. The Java program may also allow the user to perform event logging to associate particular events with glucose readings taken a certain time of day or during a particular activity (exercise, flying, driving, etc.). This data can then be uploaded to a web based diabetes management server like Carelink ® (managed by Medtronic MiniMed, Inc.). The data may also be sent to other servers, doctor's offices, parents, caregivers, or the like and insulin dosage recommendations may be made. [0034] As shown in FIG. 1, a diabetes management system according to an embodiment of the invention includes a PDA/Smartphone 100, a connector 110 and a glucose monitoring device 120. The glucose monitoring device 120 includes a glucose transmitter 125 and a subcutaneous glucose sensor 130 of the type described U.S. Patent No. 5,391,250 entitled "Method of Fabricating Thin Film Sensors", U.S. Patent No. 6,484,046 entitled "Electrochemical Analyte Sensor," U.S. Patent Nos. 5,390,671, 5,568,806 and 5,586,553, entitled "Transcutaneous Sensor Insertion Set," U.S. Patent No. 6,809,653 entitled "Telemetered Characteristic Monitor System And Method Of Using The Same," and U.S. Patent Application Serial Nos. 09/377,472, 11/225,790, 11/225,296, 11/322,568 and entitled "Telemetered Characteristic Monitor System And Method Of Using The Same," all of which are specifically incorporated by reference herein. In particular embodiments, the connector 110 has a mini-USB connector that plugs into an available port on the PDA/Smartphone 100. Upon connection, the connector 110 allows communication between the PDA/Smartphone 100 and the glucose transmitter 125. The connector 110 may be used when a user chooses to use a glucose monitoring system 120 made by a different manufacturer from the PDA/Smartphone. For example, if a diabetic wanted to use the Guardian® RT Continuous Glucose Monitoring System developed by Medtronic MiniMed, Inc. with his BlackBerry PDA/Smartphone, the user would only need the appropriate connector 110 manufactured by Medtronic MiniMed that would plug into his BlackBerry. Upon connection, the Guardian® RT system would communicate with the user's BlackBerry. [0035] The PDA/Smartphone 100 may be selected from any number of devices including the very popular BlackBerry® line of devices manufactured by Research in Motion. Other devices include the popular Treo devices produced Palm, Inc (Treo 600, 650, 680, 70Ow, 70Op, 700wx, 75Ow), the HTC line of devices (AT&T 8525, AT&T Tilt, T-Mobile Dash, T- Mobile Wing, and the like), the Apple iPhone, and the like. Other devices and connectors are of the type described in U.S. Patent Nos. 6,558,320 and 6,641,533 entitled "Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same," and U.S. Patent Application Serial No. 10/429,385 entitled" Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same," all of which are specifically incorporated by reference herein.
[0036] The connector 110 may be of the type described in U.S. Patent Application Serial No. 10/335,256 filed on December 12, 2002 and entitled "Relay Device for Transferring Information Between a Sensor System and Fluid Delivery System," which is specifically incorporated by reference herein. The connector 110 may include its own power supply or it may be powered through the connection to the CED. In some embodiments, the connector battery may charge its battery when plugged into the CED. The connector 110 allows communication between the CED and MD. In most situations, the MD will use a proprietary communication protocol that is associated with its monitor. However, the connector would communicate with the MD using the proprietary communication protocol and then relay the received data from the MD to the CED using any number of communication solutions. Such communication solutions include, but are not limited to, IR, RF, Bluetooth, wired connection via mini-USB, Wi-Fi, Zigbee, and the like.
[0037] An example of a connector for a BlackBerry device is shown in FIGs. 2 and 4. FIG 2(a) shows a front perspective view of a BlackBerry device 200 with a connector 250 attached to the BlackBerry 200 mini-USB port. As shown in the figures, the connector 250 (or comlink) would have a small profile and fit nicely on the device to avoid changing the portable nature of the BlackBerry 200. Additionally, the connector 250 would include a male end that would plug into the BlackBerry 200 and a female end 255 that would allow the BlackBerry to continue its normal functionality — plug into a power outlet to charge, plug into a computer to synchronize data, etc. In particular embodiments, the connector 250 could communicate with the BlackBerry 200 using a wireless radio contained on the BlackBerry. In this aspect, a connector 250 can be attached to the BlackBerry 200 and can carry out protocol conversion. It can speak directly with the sensor transmitter's hardware to receive the data, and then it can send that data to the BlackBerry 200 using a standard communication protocol that the BlackBerry 200 can interpret (Bluetooth, IR, Zigbee, etc.) In other embodiments, the connector 250 communicates with the BlackBerry 200 via direct communication through the mini-USB port. For other devices that don't include a mini-USB port, the connector may be adapted to take the shape of an SD card to fit in a SDIO slot, or any other memory card shape to fit in the particular CED' s available port (miniSD, microSD, memory stick, memory stick pro, memory stick duo, etc.).
[0038] Another example of a connector is shown in FIG. 4. FIG. 4(a) shows a rear perspective view of the CED 400 with a connector 450 attached to the back of the CED. FIGS. 4(b) and (c) show other perspective views of the connector 450 attached to the back of the CED. In this example, the connector may be self charged with its own power supply, or may draw power from the battery pack installed in the BlackBerry. The connector 450 shown in FIG 4 need not utilize the mini-usb plug on the BlackBerry device. Instead, the connector 450 simply attaches to the back of the CED and remains self -powered. [0039] The glucose monitoring device 120 may be replaced by any number of medical devices including, but not limited to a sensor with a built-in transmitter/receiver, a glucose monitor, a glucose meter, an insulin pump, and the like. In particular embodiments, glucose sensor 130 is a continuous glucose sensor capable of taking readings from a user on a continuous or near-continuous basis throughout the day. The glucose sensor transmitter 125 transmits blood glucose (BG) data to the connector 110 which is plugged into the CED 100. The CED 100 can take the BG data and display the information to the patient using the interface and control available on the CED 100 the user is already familiar with. [0040] In these embodiments, software may be downloaded and/or preinstalled on the CED 100 to manipulate and manage the data received from the MD 120. The CED 100 may also include drivers to use the connector. In particular embodiments, the software will be written as a Java application — allowing the user to use their Java-enabled CED 100 to control and manage the data received from the MD 120. Java is a common mobile platform utilized by over 150 carriers. Currently, there are over 1.2 billion Java-enabled handsets and 8 out of 10 new phones shipped in 2005 were Java enabled. Additionally, there are 5 million Java developers worldwide. A Java application can be installed on any CED that includes Java capabilities (BlackBerry, T-Mobile Dash, Palm Treo, etc.). The installed Java application (as shown in FIG. 5) can display the BG data and can output the data in graphs, excel sheets, multi-day trackers, etc. Other programming options include, but are not limited to Windows CE, Windows Mobile, Palm Operating System, iPhone Operating System, .NET framework, Web-based Interface (no software needed to install, just run it from a supported browser, e.g. minimo, opera, pocket IE, Safari, etc.) Utilizing a web-based interface would allow seamless updates to the software without bothering the user on their CED.
[0041] As shown in FIG. 3, a diabetes management system according to an embodiment of the invention includes an MP3 player 300, a connector 310 and a glucose monitoring device 320. The glucose monitoring device 320 includes a glucose transmitter 325 and a subcutaneous glucose sensor 330. In these embodiments, the iPod would be the CED of choice. The iPod 300 has become a world renowned device used by millions world wide. Allowing medical device management software to run on an iPod allows much more widespread use of important medical device technology — namely, the capability to receive and manage BG readings from a glucose monitoring system 320. The connector 310 may resemble the connector sold with the Nike+ iPod Sports Kit currently marketed by Nike and Apple. However, in some embodiments, the connector need not plug into the iPod connector and may communicate with the iPod and CED via wireless communication. The connector 310 would receive BG data from the glucose transmitter 325 and show the received data on the iPod 300. The iPod may be replaced by any number of MP3 and/or digital audio players including the Sansa, Zune, Gigabeat S, and the like.
[0042] In all embodiments described above, the BG data received by the CED can be manipulated by the software on the CED to show graphs, excel files, initiate reminders to check BG after a certain period of time and determine if BG readings are in a target range. In addition, software on the CED can track and manage BG information coupled with event markers inputted by the user.
[0043] In embodiments where the CED is a PDA/Smartphone, cell phone, or any other device with external communication capabilities, the CED may be configured to transmit the received BG data to external sources. For example, where the CED is a cellular PDA/Smartphone that includes cellular connectivity (voice and/or data) the software installed on the CED can transmit the received BG data (or any other data received from the MD) to the internet, caregivers, doctors, parents, and the like. The data can be transmitted via SMS, which has become a widely adopted communication mechanism all over the world. The software on the CED could be configured to send an SMS to the user's caregiver if a BG reading it too low, too high, or even if the user forgot to check his/her BG levels in for example, the last hour. In addition to SMS messages, the software on the CED may use the CED' s internet connection to upload data to a central medical server or relay a message to a hospital, emergency room, or parent's email address. The communication to the internet may be accomplished using the CED' s internet connection over Wi-Fi, GPRS, EDGE, IxRTT, EV-DO, UMTS/HSDPA, or USB tethering. In addition, the software may use a CED' s Bluetooth radio to send and/or synchronize data with the user's Bluetooth enabled PC and/or Bluetooth enabled automobile which has glucose sensing capabilities of the type described in U.S. Patent Application Serial No. 11/466,532 filed on August 23, 2006 and entitled "Automobile Glucose Sensor Monitoring System and Method of Using the Same," which is specifically incorporated by reference herein.
[0044] Utilizing the CED' s wireless radios (cellular, Wi-Fi, Bluetooth, RF, Infrared, etc), the BG data may be sent to CEDs, other MDs, and/or uploaded to the internet to a Central Server. Once the data is on the central server, the server can manipulate the data and send information to other CEDs and other MDs, or send the information to a nurse or doctor. When the data is transmitted to any of the sources discussed above, secure communication may be achieved by encrypting the data.
[0045] In further embodiments, where the CED is a device with cellular capabilities (PDA/Smartphone, etc.), important information can be conveyed to others utilizing a cellular voice connection. In these embodiments, the software can provoke the CED to place a telephone call to selected phone numbers based on the event and/or situation at hand. The software may include pre-recorded messages that are played if a certain event takes place. Some events include out-of-range BG readings, imminent or current hypo- or hyperglycemic events, sensor calibration requirements, and the like. This particular feature may be useful for parents of diabetic children using continuous glucose monitoring systems. [0046] In additional embodiments, the CED and MD would communicate directly with each other, without the need for a connector. In this case, the MD would include a standardized communication protocol compatible with the CED. Examples include: Wireless RF Communication (Bluetooth, Wi-Fi, ZigBee, etc.), Wireless IR Communication (irda, etc.), Wired communication using serial, usb, firewire, parallel, and the like. All functions would work similarly as described in the embodiments above.
[0047] In other embodiments, the software installed on the CED may also include an alarm function that utilizes the CED 's hardware to alert and/or remind the user. Alarms may be included to notify the patient of potential crashes (hypo, hyper). Based on specific algorithms, the software can calculate predicted crashes based on BG trends. The user may be notified by an alarm included in the CED. Most PDA/Smartphones include some alert mechanism including auditory, tactile and visual that may be utilized by the software. The alarms may include differing sounds, colors, lights, vibrations, etc. In some embodiments, the alarm may be contained on the connector. If the connector has its own power supply, an alarm could be included to alert the patient of the above mentioned situations. In still other embodiments, the alarm may be included on the MD. The MD may send signals over to the connector and/or the CED to initiate an audio, tactile, or visual alarm. [0048] The software installed on the CED may utilize multiple algorithms to manage and control the CED. A first algorithm may be a sensor data algorithm which allows the CED to obtain, store and display the BG data from the MD.
[0049] A second algorithm may be a patient event algorithm that associates a particular event during a particular time of day to a set of BG readings obtained from the sensor during that time period. The user can manually input their activity (What event is taking place?) and the software associates the subsequent BG readings with that particular event. Examples of events include eating (what type of food?), exercising, hot air ballooning, driving fast in a car, and the like. The events can be predefined by the software and/or customizable by the user. In addition, the software may ask the user of the event duration. If the event duration is known, then BG readings can be synchronized with the event. Using this event information, the BG values associated with that time period can be obtained and managed in a central server when the data is uploaded using any of the communication methods described above. With this information, doctors and medical analysts can determine effects on BG levels when patients participate in particular activities or eat particular foods. This data can be stored on the CED, the connector, or the MD and can subsequently be uploaded to a central server where all of the information can be managed (i.e., Carelink).
[0050] In still other embodiments, a food library can be created, maintained and updated using the event information. The food library can be stored on the CED, MD, and/or the connector. The user can constantly receive updates to the library via internet, SMS, etc. With an event logging algorithm, the food library may be maintained by scientists at a diabetes management facility. They can look at groups of patients and determine the effects certain foods and activities have based on user profiles. From there, "Results" are stored and accessible by other patients for reference purposes.
[0051] The software may also be capable of running Virtual Patient programs on the CED, MD and/or the connector. Some virtual patient programs allow patients and physicians to simulate BG responses based on a set of predefined variables.
[0052] In still further embodiments, the MD may be a continuous glucose monitoring system where the glucose sensor and glucose transmitter are fused into one device having a small profile. In addition, the glucose sensor/transmitter combination may perform all the processing of the BG data. Then the CED becomes a simple device that receives data and manipulates it. In still other embodiments, the CED may not be required because the glucose sensor/transmitter may have a display, controls, and wired/wireless connection to upload information to a central server, SMS functionality, and/or email capability. [0053] FIG. 5 shows an example of the MD software 520 running on a CED 500 in an embodiment of the invention. In this particular figure, a BlackBerry (model 8800) is used to show the Java program running the MD software. As shows in FIG. 5, the software 520 displays information to the patient using the CED 500. This information includes current BG levels, the time of day, signal strength (of the cellular connection and/or of the connection to the MD), target blood glucose ranges and specific event markers. Each of these elements will be further described below. In addition, the patient can utilize the input functionality 540 of the CED 500 to setup and program their CED to control the MD. Input functionality 540 includes the BlackBerry' s keyboard, scroll wheel, function keys, and the like. [0054] FIG. 6 shows a flow diagram describing the operation of a particular embodiment of the diabetes management system. In this example, a BlackBerry device serves as the CED and a glucose sensor functions as the MD. In step 600, the BlackBerry device is powered on. The BlackBerry must then be paired with the connector as described in step 602. If the connector is not yet paired, the user moves to step 604 and proceeds in pairing the connector with the BlackBerry. Standard methods of pairing Bluetooth devices are involved in the process. In particular, the connector may be placed in a Bluetooth discovery mode by holding down the power button on the connector. While the connector is in the discovery mode, the user must navigate to the Bluetooth connection menu in the BlackBerry and search for devices. Once the connector is found by the BlackBerry, the user will have to enter in a unique identifier code specific to their particular connector. The code should be found in the connector documentation. Once the correct code is entered, the connecter is paired with the BlackBerry.
[0055] Once the Bluetooth pairing between the BlackBerry and the connector is complete, the patient then moves on to step 606 to confirm communication with the connector. The sensor's ID must next be entered (step 610) into the BlackBerry and synchronized (step 608). After the unique sensor ID is entered (step 610), communication between the BlackBerry and the sensor (via the connector) is confirmed. If the sensor is detected in step 612, then the patient must wait for the sensor to initialize and enter normal operation (step 616). If the sensor in not detected, then the patient must search and pair with the sensor as described in step 614. After searching, pairing and initialization of the sensor in normal mode, the patient must then enter a blood glucose value obtained from a finger stick meter to calibrate the sensor. However, in some embodiments, this finger stick BG value may be excluded. In these embodiments, the sensor may have built calibration algorithms not requiring the finger stick BG value. In still further embodiments, the CED, MD and/or connector may include a built-in blood glucose meter for obtaining finger stick BG measurements. [0056] After step 618 is complete, the glucose sensor monitor is now operational and the BlackBerry can receive the monitored BG values (step 620). As shown in the flow diagram, re-calibration may be needed after a certain amount of time has elapsed (i.e., every 3, 6, or 12 hours). If this is the case, the user will be reminded to re-calibrate and enter a new BG value. The patient may need to wait for a certain period of time for the sensor to re-calibrate (Le,. 5, 10, 20 minutes). However, in some embodiments, there may be no waiting time necessary. In addition, after the glucose sensor has reached its end of life, a new glucose sensor must be obtained, and the sensor pairing process must take place again (step 610). In step 622, if a message is received from the connector (Bluetooth module), then the data may be processed (step 624). The data may be processed by the MD, the connector, and/or the BlackBerry. [0057] In FIG. 7, sample screenshots of the software's graphical user interface are shown. In these particular embodiments, FIG. 7 (a) shows the GUI of the software running on the CED including a unit of time for the time axis (700); the date and time (702); and signal strength (704). The time axis 700 may be adjustable by the user and can range from displayed minute by minute increments to hourly, daily, weekly, monthly and/or yearly increments. The signal strength bars 704 may define the strength of the connection between the CED and the MD. In some instances, the user may toggle the indicator 704 to show the CED cellular signal connection also. The graph region 706 shows the blood glucose axis which defines ranges of BG levels. Range 710 shows a hyperglycemic region and is colored blue. The normal or target region 712 is defined by a green color indicating good control. The hypoglycemic region 714 is defined by a red color. The time axis is shown in 708 and, as described above, can be adjusted by the user for zooming in and out for a particular time ranges. Event bar 716 identifies specific markers placed by the patient and/or by the software to associate these values obtained during that time period with a specific event. Finally, data bar 718 confirms that BG data for a specific time period was received.
[0058] FIG. 7(b) points out the cursor 720 which is adjustable by the patient. The patient can move the cursor along the plot of data points using the CED 's input function (keyboard, scroll wheel, arrow keys, and the like). Once the cursor 720 is highlighted, the patient's BG reading for the data point is shown in 722. The main menu 724 of the software is also shown in FIG. 7(b). The main menu 724 shows the patient his/her available options in customizing and accessing the various features of the software. A more detailed explanation of the various sub-menus is described below. Also, FIG. 7(b) shows an example of missing data 728 and how the data bar 718 shows a blank white space during the time no data was received. Event marker 726 shows in event bar 716 that a meal was eaten at that particular time. The graph shown in FIG. 7 describes one possible view of the GUI as used in an embodiment of the invention. However, in further embodiments, simpler or more complex GUIs may be used to provide the patient with more or less data. Simpler graphs may be used and/or no graphs may be shown. In some embodiments, the patient may customize the home screen of the software. Customizations may allow the patient to define specific variables. In even further embodiments, predefined screen layouts may exist on the software which allow doctors and clinicians to view more detailed graphs and charts (an "expert mode"). If an expert mode were included, an everyday "patient mode" might also be included utilizing some or all of the elements shows in FIG. 7.
[0059] FIG. 8 shows screenshots of how the patient and/or doctor might set up target blood glucose threshold profiles for different times of day. As shown in FIG. 8(a), the ranges of blue (710), green (712), and red (714) regions fluctuate based on specific time periods. This function is useful since patients can sit down with their physician to determine what range their BG values should fall in during different times of the day (while sleeping, during work, in the morning, etc.). In addition, it also allows the patient to avoid extra alarms that would occur if there was only one specific range tied to each region. The more a patient understands his/her body, the better they will be able to define their BG threshold ranges. As shown in FIG. 8(b), the target BG selection screen allows the patient to add multiple profiles. In the screenshot shown in FIG. 8(b), the patient has entered three profiles: (1) From 0:00 - 8:00, threshold of 80 - 140 mg/dL; (2) From 8:00 - 17:30, threshold of 70 - 156 mg/dL; and (3) From 17:30 - 24:00 (0:00), threshold of 95 - 145 mg/dL. The patient may add additional profiles by clicking on the "Add New Profile" as shown in FIG. 8(b). The new profile screen is shown in FIG. 8(c), where the user enters the lower threshold, upper threshold, and start time of the profile. The end time is always the start of the next profile or 24:00 (0:00) if no sequential profile exists. When entering a start time, it must be 30 minutes after the previous profile. The user may also delete profiles which simply removes that profile. The graph on the main screen will be updated to display all profiles. In other embodiments, the patient may adjust the 30 minute value between profiles to better match his/her therapeutic needs. In some cases the timing may be longer or shorter based on each situation. In further embodiments, this value may or may not be adjustable by the patient. [0060] FIGs. 9-15 go through the various sub-menus of the functions available in the main menu 724 (FIG. 7(b)) of the software in particular embodiments of the invention. FIG. 9 shows the menu structure for the first heading under main menu 724 — Meter BG (900). The "Meter BG" sub-menu is shown in 902. This menu allows the patient to enter in his/her current blood glucose obtained from a finger stick measurement. In addition, as shown in 902, a reminder is included under the first screen stating when the next BG reading is due. Two functions are included in sub-menu 902 — BG Reminder and BG History. The BG History menu is show in 904 and it shows a log of the past BG values entered by the patient. Screenshot 906 shows the box that is pulled up when the patient highlights and selects a particular reading listed in screenshot 904. Again, in some embodiments, the meter BG readings are necessary to calibrate the sensor and assure proper and accurate sensor readings. In some cases, reading should be obtained every 3, 6, or 12 hours. However, in other embodiments, a meter BG value may only be required once a new sensor is utilized. In still further embodiments, no meter BG value is needed. Some embodiments may include a finger stick BG meter on the MD itself, built-in on the connector, and/or even built in to the CED. [0061] Also shown in screenshot 902 is a BG Reminder button. The BG Reminder button pulls up the BG Reminder Entry sub-menu shown in 908. This allows the patient to configure a reminder/alarm to remind the patient that an upcoming BG value entry is required. The patient may choose any time frame. As shown in screenshot 908, the patient has entered a 1 hour and 45 minute reminder. The software may have predefined minimum and maximum values that are not adjustable by the patient to assure compliance. The range may be between 2 hours and 10 minutes. Other periods may range from 4 hours to 5 minutes, and the like. The BG Entry Reminder screen 908 also allows the patient to configure the indication mechanism with a choice between MMS/SMS Setup, Snooze, and Alert Type. The MMS/SMS setup screen 914 allows the patient to select a contact to receive an SMS reminding the patient or whichever contact is chose, that a BG value entry is due. The user may enter in a telephone number capable of receiving an SMS or select a contact already saved in the user's BlackBerry device. In addition, the software may also include a further menu allowing the patient to configure an automatic phone call to be placed to a specific contact in the event a BG value entry is due. More on this topic will be covered below in the hypo- and hyperglycemic alarms section.
[0062] The Setup Alarm Snooze screen 912 allows the patient to configure the snooze interval. Again, the software may include predefined and/or non-customizable time periods. But generally, the patient will be able to choose the timeframe. Finally, the Setup Alert Type screenshot 910 allows the patient to select an audio file to play when the reminder comes up. The files may be selected from audio files contained within the software itself (i.e., wav, midi, mp3, aac, aiff, m4a, and the like). In other embodiments, the patient may explore the BlackBerry device to select an audio file stored on the device's hard drive or external memory card. The patient may also have the software initiate a vibration alarm as well as an audio alert when the reminder is due. In further embodiments, a visual alert mechanism may also be utilized in the form of flashing LEDs or flashing screens. In some embodiments, the patient may pick and choose which type of alert mechanism he or she would like for each particular event reminder and/or alarm.
[0063] In FIG. 10, screenshot 1000 again shows the main menu (724) and the Alarm History sub-menu is shown in 1010. In this screenshot, the patient can view all previous alarms and alerts that were activated. Alarms and alerts can occur for simple reminders to take a meter BG reading, to more serious concerns of potential hypo- or hyperglycemic events or lost signal strength between the glucose sensor and the CED. The history screen is especially useful for doctors, caregivers and even parents who are monitoring their loved ones. [0064] FIG. 11 shows the main menu in screenshot 1100 with the third highlighted submenu — Alerts. In sub-menu 1102, the patient can configure their Glycemic Alerts choosing from three separate categories — Glucose Range, Predict Hypoglycemia, and Predict Hyperglycemia. In the Target BG Selection screen 1104, the patient can set up his/her target BG values for various time periods throughout the day. Again, as described above, the patient enters the lower threshold, upper threshold, and start time of the profile as shown in screenshot 1106 (see also FIG. 8). In screenshot 1104, the patient can configure the indication mechanism as described above — via the MMS/SMS Setup screen (1116), Snooze screen (1114), and Alert Type screen (1112).
[0065] Screenshots 1108 and 1110 allow the patient to configure the Low BG and High BG predictive alarms. If the software determines that the patient's BG values are trending down or up and will fall outside the patient's target range, an alarm may issue. The patient can set up a Time To Limit Breach and a Rate of Change for both screens. Again, in some embodiments, the predictive alarms shown in 1108 and 1110 may be important alerts that doctors, caregivers and/or parents would like to be aware of. Accordingly, both alarms can be configured to send an SMS message (1116) or even initiate a telephone call to a phonebook contact or emergency service provide as discussed above. In some embodiments, the patient may access a different screen (not shown) to specify which contact should be called. In these screens, pre-recorded messages may be selectable so they can be played back to the recipient of the telephone call when a specific alert and/or alarm is activated. In additional embodiments, the patient may be able to configure the text contained within the SMS (or text message) sent to their phonebook contact or cellular number that is entered in screenshot 1116 or predefined text messages may be used. The algorithms of the predictive glycemic alarms may be of the type used in on-the-market insulin infusion devices and/or glucose monitoring systems.
[0066] In FIG. 12, the patient accesses the main menu as shown in screenshot 1200 and selects sub-menu "Sensor". This takes the patient to the Transmitter Setup screen shown in 1202. The patient can review the sensor ID code, as well as re- synchronize the sensor or set up and pair a new sensor. In addition, the patient can review the sensor statistics as shown in screenshot 1204. Screenshot 1204 may provide the patient with sensor life information, sensor value discrepancy between recent BG meter readings, battery voltage, and the like. From the Transmitter Setup screen 1202, the patient may also access the No-Telem Reminder screen 1206. In screen 1206, the patient can configure a reminder alert if communication between the sensor and the connector is lost for more than X minutes. The alerts that issue may be configured as shown in screens 1208, 1210, and 1212.
[0067] FIG. 13 shows the another sub-menu accessible by the patient in certain embodiments of the present invention. As shown in screen 1300, Events is the next selection and its screenshot is shown in 1302. Here the patient can configure the event markers as discussed above. In particular embodiments, the patient can choose from pre-defined events contained within the software and/or customizable events of varying duration. As shown in screen 1304, the patient can configure an Insulin Event to let the software know that a certain amount of insulin was administered at a particular time of day. Screenshot 1304 also allows input of the type of insulin administered (i.e., fast-acting, long-acting, inhalable, and the like). Screenshot 1306 allows the patient to configure a Meal Event market. Again, after the patient inputs the time and date, carbohydrate content and fat content can be entered. In yet additional embodiments, the software may include pre-defined food libraries from which the patient can select meals consumed. Further menus may allow the patient to select a predefined meal but customized to the patient's specific desire. Screenshot 1308 allows the patient to configure a User Defined Event. In this selection, the patient can enter in as much data as they feel appropriate to describe the specific activity taking place. When the data is uploaded to the diabetes management company and/or the patient's doctor, information can be obtained as to the effects on BG levels associated with the described activities. Screenshot 1310 allows the patient to configure an Exercise Event in terms of duration. In further embodiments, the patient may describe and/or choose from specific exercise activities including, but not limited to weightlifting, running, swimming, aerobics, yoga, and the like. Finally, screenshot 1312 pulls up an Events History screen where the patient can review previous events. In further embodiments, the patient may set up event markers before the event actually takes place. For example, if the patient works out every other day between 8:00am and 9:00am, the patient may set up an exercise event marker for those days beforehand. In further embodiments, the Events menu may include an indication mechanism selection to send data out to doctors, caregivers and/or parents regarding specific activities patients are participating in.
[0068] In FIG. 14, that patient can define the indication profile to be used on the CED. Screen 1400 shows the available options: Normal, Vibrate and Silent. The Normal profile will issue audio alerts based on specific alarms and reminders discussed above. The Vibrate profile issues tactile indications based on the same. In some embodiments, the user may select one or both profiles to occur simultaneously. The user may also select neither profile and, instead, may choose the Silent profile. Screenshot 1410 shows the sub-menu that is displayed when the Silent profile is selected. In particular, 1410 shows an Alarm Masking Duration menu where the patient enters a duration of time to disable upcoming alarms. This function may or may not be enabled in certain embodiments and may be customizable in other embodiments. In some cases, a parent who monitors his/her child may wish to disable this function entirely. Minimums and maximums may be predefined in the software and/or user selectable.
[0069] In FIG. 15, a sample screenshot 1500 is shown of a hypoglycemic alarm. In particular, the alarm may be accompanied by an audio and vibratory alert. The screen may display the name of the alarm (in this case, hypoglycemia). In addition, the activation of the alarm may indicate an SMS being sent to a loved one and/or telephone call being placed to emergency services as described above. In some embodiments, the patient may disable the alarm by acknowledging the indication. In other embodiments, certain alarms may not get dismissed until the patient does some corrective action as identified by the software. [0070] The menu structure described in FIG. 9-15 describe a set of sample menus that may be included in embodiments of the diabetes management system. It shall be understood that additional and/or different menu screens may be included and/or excluded based on the particular CED, connector and MD components being utilized in the system. For example, if the CED is an MP3 player (i.e., the iPod Touch), different screen layouts and designs may be utilized in accordance with the above described embodiments utilizing the CEDs specific features (multi-touch touchscreen, accelerometers, proximity sensors, and the like). In further embodiments, the menu screens may be contained on the connector and not included on the CED at all.
[0071] While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention.
[0072] The presently disclosed embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims, rather than the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.

Claims

CLAIMSWhat Is Claimed Is:
1. A system for managing diabetes using a consumer electronic device, the system comprising: a medical device for taking a physiological reading of a user, wherein the medical device includes a transmitter for communicating the physiological readings; a consumer electronic device, wherein the consumer electronic device includes software for managing and processing data obtained by the medical device; and a connector removably coupled to the consumer electronic device for facilitating communication between the medical device and the consumer electronic device; wherein the connector receives data from the medical device in a first communication protocol, and the connector transmits data to the consumer electronic device in a second communication protocol.
2. The system according to claim 1, wherein the medical device is a continuous glucose monitoring system.
3. The system according to claim 1, wherein the medical device is an infusion device.
4. The system according to claim 1, wherein the consumer electronic device is a Smartphone.
5. The system according to claim 1, wherein the consumer electronic device is an MP3 player.
6. The system according to claim 1, wherein the software is a Java application.
7. The system according to claim 4, wherein the Smartphone transmits the received data to a central server using an internet connection.
8. The system according to claim 4, wherein the Smartphone transmits the received data to a different cellular phone using SMS.
9. The system according to claim 4, wherein the Smartphone initiates a cellular phone call based on a particular event.
10. The system according to claim 1, wherein the software includes alarm capabilities to alert the user of a particular event.
11. The system according to claim 1, wherein the first communication protocol is a proprietary protocol maintained by the medical device manufacturer and the second communication protocol is Bluetooth.
12. A method for managing diabetes using a consumer electronic device, the method comprising the steps of: pairing a connector to a consumer electronic device; programming the consumer electronic device to communicate with a medical device for taking a physiological reading of a user, wherein the medical device is pre-programmed to communicate with the connector, allowing communication between the consumer electronic device and the medical device thorough the connector; sending data from the medical device to the consumer electronic device via the connector; and processing and displaying the data on the consumer electronic device.
13. The method according to claim 12, wherein the medical device is a continuous glucose monitoring system.
14. The method according to claim 12, wherein the consumer electronic device is a Smartphone.
15. A system for providing information obtained from a medical device to an individual at a remote location, the system comprising: a medical device for taking a physiological reading of a user, wherein the medical device includes a transmitter for communicating the physiological readings; a local consumer electronic device, wherein the local consumer electronic device includes software for receiving, managing and processing data obtained by the medical device; a connector removably coupled to the local consumer electronic device for facilitating communication between the medical device and the local consumer electronic device; and a remote consumer electronic device for receiving information sent from the local consumer electronic device, wherein the connector receives data from the medical device in a first communication protocol, and the connector transmits data to the local consumer electronic device in a second communication protocol; and wherein the remote consumer electronic device receives information from the local consumer electronic device through a third communication protocol.
16. The system according to claim 15, wherein the first communication protocol is a proprietary protocol maintained by the medical device manufacturer, the second communication protocol is Bluetooth, and the third communication protocol is cellular communication.
17. The system according to claim 16, wherein the cellular communication allows the local consumer electronic device to send information to the remote consumer electronic device using SMS, MMS, or email.
18. A connector for use with a consumer electronic device and a medical device, the connector comprising: a connecting structure for attaching the connector to the consumer electronic device; a power supply for providing power to the connector; a first communication protocol for transmitting data between the medical device and the connector; and a second communication protocol for transmitting data between the connector and the consumer electronic device.
19. The connector according to claim 16, wherein the first communication protocol is a proprietary protocol maintained by a manufacturer of the medical device and the second communication protocol is Bluetooth.
20. A software-based application for receiving, managing and processing medical device data on a consumer electronic device, the software -based application comprising: a graphical user interface for displaying data to a patient; an input mechanism for use by the patient to adjust settings in the software-based application; and alarms for alerting and reminding the patient.
EP07868762A2006-11-172007-11-15System and method for diabetes management using consumer electronic devicesCeasedEP2084634A2 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
EP11177237AEP2386971A3 (en)2006-11-172007-11-15System and methods for diabetes management using consumer electronic devices

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US86640906P2006-11-172006-11-17
US11/931,363US20080119705A1 (en)2006-11-172007-10-31Systems and Methods for Diabetes Management Using Consumer Electronic Devices
PCT/US2007/084769WO2008064053A2 (en)2006-11-172007-11-15System and method for diabetes management using consumer electronic devices

Publications (1)

Publication NumberPublication Date
EP2084634A2true EP2084634A2 (en)2009-08-05

Family

ID=39417764

Family Applications (2)

Application NumberTitlePriority DateFiling Date
EP11177237ACeasedEP2386971A3 (en)2006-11-172007-11-15System and methods for diabetes management using consumer electronic devices
EP07868762ACeasedEP2084634A2 (en)2006-11-172007-11-15System and method for diabetes management using consumer electronic devices

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
EP11177237ACeasedEP2386971A3 (en)2006-11-172007-11-15System and methods for diabetes management using consumer electronic devices

Country Status (5)

CountryLink
US (1)US20080119705A1 (en)
EP (2)EP2386971A3 (en)
JP (2)JP5259611B2 (en)
CA (1)CA2667386C (en)
WO (1)WO2008064053A2 (en)

Families Citing this family (268)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7873589B2 (en)2001-04-022011-01-18Invivodata, Inc.Operation and method for prediction and management of the validity of subject reported data
US20080172026A1 (en)2006-10-172008-07-17Blomquist Michael LInsulin pump having a suspension bolus
US7811231B2 (en)2002-12-312010-10-12Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US7587287B2 (en)2003-04-042009-09-08Abbott Diabetes Care Inc.Method and system for transferring analyte test data
US7679407B2 (en)2003-04-282010-03-16Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US8460243B2 (en)2003-06-102013-06-11Abbott Diabetes Care Inc.Glucose measuring module and insulin pump combination
US7722536B2 (en)2003-07-152010-05-25Abbott Diabetes Care Inc.Glucose measuring device integrated into a holster for a personal area network device
US7920906B2 (en)2005-03-102011-04-05Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
WO2005089103A2 (en)2004-02-172005-09-29Therasense, Inc.Method and system for providing data communication in continuous glucose monitoring and management system
EP1810185A4 (en)2004-06-042010-01-06Therasense IncDiabetes care host-client architecture and data management system
US7654956B2 (en)2004-07-132010-02-02Dexcom, Inc.Transcutaneous analyte sensor
US8029441B2 (en)2006-02-282011-10-04Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management system
US9636450B2 (en)2007-02-192017-05-02Udo HossPump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9788771B2 (en)2006-10-232017-10-17Abbott Diabetes Care Inc.Variable speed sensor insertion devices and methods of use
US7545272B2 (en)2005-02-082009-06-09Therasense, Inc.RF tag on test strips, test strip vials and boxes
EP3827747A1 (en)2005-04-282021-06-02Otsuka Pharmaceutical Co., Ltd.Pharma-informatics system
US8802183B2 (en)2005-04-282014-08-12Proteus Digital Health, Inc.Communication system with enhanced partial power source and method of manufacturing same
US9198608B2 (en)2005-04-282015-12-01Proteus Digital Health, Inc.Communication system incorporated in a container
US8730031B2 (en)2005-04-282014-05-20Proteus Digital Health, Inc.Communication system using an implantable device
US8912908B2 (en)2005-04-282014-12-16Proteus Digital Health, Inc.Communication system with remote activation
US8836513B2 (en)2006-04-282014-09-16Proteus Digital Health, Inc.Communication system incorporated in an ingestible product
US7768408B2 (en)2005-05-172010-08-03Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
JP2009507224A (en)2005-08-312009-02-19ユニヴァーシティー オブ ヴァージニア パテント ファンデーション Improving the accuracy of continuous glucose sensors
US8547248B2 (en)2005-09-012013-10-01Proteus Digital Health, Inc.Implantable zero-wire communications system
US8880138B2 (en)2005-09-302014-11-04Abbott Diabetes Care Inc.Device for channeling fluid and methods of use
US7583190B2 (en)2005-10-312009-09-01Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systems
US7826879B2 (en)2006-02-282010-11-02Abbott Diabetes Care Inc.Analyte sensors and methods of use
US8478557B2 (en)2009-07-312013-07-02Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracy
US9392969B2 (en)2008-08-312016-07-19Abbott Diabetes Care Inc.Closed loop control and signal attenuation detection
US8219173B2 (en)2008-09-302012-07-10Abbott Diabetes Care Inc.Optimizing analyte sensor calibration
US9675290B2 (en)2012-10-302017-06-13Abbott Diabetes Care Inc.Sensitivity calibration of in vivo sensors used to measure analyte concentration
US7801582B2 (en)2006-03-312010-09-21Abbott Diabetes Care Inc.Analyte monitoring and management system and methods therefor
US9326709B2 (en)2010-03-102016-05-03Abbott Diabetes Care Inc.Systems, devices and methods for managing glucose levels
US7620438B2 (en)2006-03-312009-11-17Abbott Diabetes Care Inc.Method and system for powering an electronic device
JP2009544338A (en)2006-05-022009-12-17プロテウス バイオメディカル インコーポレイテッド Treatment regimen customized to the patient
US8202267B2 (en)*2006-10-102012-06-19Medsolve Technologies, Inc.Method and apparatus for infusing liquid to a body
EP2087589B1 (en)2006-10-172011-11-23Proteus Biomedical, Inc.Low voltage oscillator for medical devices
SG175681A1 (en)2006-10-252011-11-28Proteus Biomedical IncControlled activation ingestible identifier
US8718193B2 (en)2006-11-202014-05-06Proteus Digital Health, Inc.Active signal processing personal health signal receivers
US20080161754A1 (en)*2006-12-292008-07-03Medsolve Technologies, Inc.Method and apparatus for infusing liquid to a body
CN101686800A (en)2007-02-012010-03-31普罗秋斯生物医学公司Ingestible Event Marker System
US8956288B2 (en)2007-02-142015-02-17Proteus Digital Health, Inc.In-body power source having high surface area electrode
US20080199894A1 (en)2007-02-152008-08-21Abbott Diabetes Care, Inc.Device and method for automatic data acquisition and/or detection
US8123686B2 (en)2007-03-012012-02-28Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
EP2063771A1 (en)2007-03-092009-06-03Proteus Biomedical, Inc.In-body device having a deployable antenna
EP2124725A1 (en)2007-03-092009-12-02Proteus Biomedical, Inc.In-body device having a multi-directional transmitter
EP2137637A4 (en)*2007-04-142012-06-20Abbott Diabetes Care IncMethod and apparatus for providing data processing and control in medical communication system
US10111608B2 (en)2007-04-142018-10-30Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication system
CA2683953C (en)2007-04-142016-08-02Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication system
WO2008130897A2 (en)2007-04-142008-10-30Abbott Diabetes Care, Inc.Method and apparatus for providing data processing and control in medical communication system
WO2008130898A1 (en)2007-04-142008-10-30Abbott Diabetes Care, Inc.Method and apparatus for providing data processing and control in medical communication system
US7928850B2 (en)2007-05-082011-04-19Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8461985B2 (en)2007-05-082013-06-11Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8456301B2 (en)2007-05-082013-06-04Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8665091B2 (en)2007-05-082014-03-04Abbott Diabetes Care Inc.Method and device for determining elapsed sensor life
US20080281171A1 (en)*2007-05-082008-11-13Abbott Diabetes Care, Inc.Analyte monitoring system and methods
US8239166B2 (en)2007-05-142012-08-07Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en)2007-05-142013-05-21Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en)2007-05-142018-06-19Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en)2007-05-142012-09-04Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en)2007-05-142013-12-03Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en)2007-05-142012-01-24Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en)2007-05-142015-09-08Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en)2007-05-142013-10-15Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8115618B2 (en)2007-05-242012-02-14Proteus Biomedical, Inc.RFID antenna for in-body device
TW200911773A (en)*2007-06-122009-03-16SolvayEpichlorohydrin, manufacturing process and use
AU2008265542B2 (en)2007-06-212014-07-24Abbott Diabetes Care Inc.Health monitor
WO2008157820A1 (en)2007-06-212008-12-24Abbott Diabetes Care, Inc.Health management devices and methods
US8160900B2 (en)2007-06-292012-04-17Abbott Diabetes Care Inc.Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8834366B2 (en)2007-07-312014-09-16Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibration
DK2192946T3 (en)2007-09-252022-11-21Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
US20090164239A1 (en)2007-12-192009-06-25Abbott Diabetes Care, Inc.Dynamic Display Of Glucose Information
US20090177147A1 (en)2008-01-072009-07-09Michael BlomquistInsulin pump with insulin therapy coaching
US8708961B2 (en)*2008-01-282014-04-29Medsolve Technologies, Inc.Apparatus for infusing liquid to a body
EP2252196A4 (en)2008-02-212013-05-15Dexcom IncSystems and methods for processing, transmitting and displaying sensor data
CN104376659B (en)2008-03-052019-10-25普罗透斯数字保健公司The ingestible event flag of multi-modal communications and system, and the method using it
US10624577B2 (en)2008-04-042020-04-21Hygieia, Inc.Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
US9220456B2 (en)2008-04-042015-12-29Hygieia, Inc.Systems, methods and devices for achieving glycemic balance
ES2670793T3 (en)2008-04-042018-06-01Hygieia, Inc. Apparatus for optimizing an insulin dosage regimen for a patient
EP2982383B1 (en)2008-04-102019-05-15Abbott Diabetes Care, Inc.Method for sterilizing an analyte sensor
US7826382B2 (en)2008-05-302010-11-02Abbott Diabetes Care Inc.Close proximity communication device and methods
KR20140117698A (en)*2008-07-072014-10-07아가매트릭스, 인코포레이티드Integrated blood glucose measurement device
AU2009268827B2 (en)2008-07-082013-10-24Proteus Digital Health, Inc.Ingestible event marker data framework
US8380531B2 (en)2008-07-252013-02-19Invivodata, Inc.Clinical trial endpoint development process
MY154217A (en)2008-08-132015-05-15Proteus Digital Health IncIngestible circuitry
US20100095229A1 (en)*2008-09-182010-04-15Abbott Diabetes Care, Inc.Graphical user interface for glucose monitoring system
WO2010056718A2 (en)2008-11-112010-05-20Hygieia, Inc.Apparatus and system for diabetes management
US8036748B2 (en)2008-11-132011-10-11Proteus Biomedical, Inc.Ingestible therapy activator system and method
EP2358270A4 (en)2008-12-112014-08-13Proteus Digital Health IncEvaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
TWI503101B (en)2008-12-152015-10-11Proteus Digital Health IncBody-associated receiver and method
US9439566B2 (en)2008-12-152016-09-13Proteus Digital Health, Inc.Re-wearable wireless device
US9659423B2 (en)2008-12-152017-05-23Proteus Digital Health, Inc.Personal authentication apparatus system and method
SG172847A1 (en)2009-01-062011-08-29Proteus Biomedical IncPharmaceutical dosages delivery system
KR20110103446A (en)2009-01-062011-09-20프로테우스 바이오메디컬, 인코포레이티드 Intake-Related Biofeedback and Individualized Medical Treatment Methods and Systems
US9402544B2 (en)2009-02-032016-08-02Abbott Diabetes Care Inc.Analyte sensor and apparatus for insertion of the sensor
EP2393415B1 (en)*2009-02-042015-11-25Sanofi-Aventis Deutschland GmbHMedical system and method for providing information for glycemic control
US20110184748A1 (en)*2009-03-042011-07-28Michael FierroSelf-administered patient healthcare management system
WO2010111403A2 (en)2009-03-252010-09-30Proteus Biomedical, Inc.Probablistic pharmacokinetic and pharmacodynamic modeling
US20100249965A1 (en)*2009-03-312010-09-30Agamatrix, Inc.Integrated Blood Glucose Measurement Device
EP3906845A1 (en)2009-04-282021-11-10Otsuka Pharmaceutical Co., Ltd.Highly reliable ingestible event markers
WO2010127050A1 (en)2009-04-282010-11-04Abbott Diabetes Care Inc.Error detection in critical repeating data in a wireless sensor system
EP2425209A4 (en)2009-04-292013-01-09Abbott Diabetes Care Inc METHOD AND SYSTEM FOR PROVIDING REAL-TIME ANALYTE SENSOR CALIBRATION WITH RETROSPECTIVE FILLING
US8368556B2 (en)2009-04-292013-02-05Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management system
EP2432458A4 (en)2009-05-122014-02-12Proteus Digital Health IncIngestible event markers comprising an ingestible component
WO2010138856A1 (en)2009-05-292010-12-02Abbott Diabetes Care Inc.Medical device antenna systems having external antenna configurations
US8636661B2 (en)*2009-06-042014-01-28Roche Diagnostics Operations, Inc.Embeddable modules for measuring blood glucose levels
US20100331645A1 (en)*2009-06-252010-12-30Roche Diagnostics Operations, Inc.Methods and systems for wireless communication between a blood glucose meter and a portable communication device
US20100331652A1 (en)*2009-06-292010-12-30Roche Diagnostics Operations, Inc.Modular diabetes management systems
US9218453B2 (en)2009-06-292015-12-22Roche Diabetes Care, Inc.Blood glucose management and interface systems and methods
FI20095791A0 (en)2009-07-152009-07-15Ihq Medical Inc Procedure and arrangements for checking measurement
DK3689237T3 (en)2009-07-232021-08-16Abbott Diabetes Care Inc Method of preparation and system for continuous analyte measurement
EP2724739B1 (en)2009-07-302015-07-01Tandem Diabetes Care, Inc.Portable infusion pump system
US8558563B2 (en)2009-08-212013-10-15Proteus Digital Health, Inc.Apparatus and method for measuring biochemical parameters
US8993331B2 (en)2009-08-312015-03-31Abbott Diabetes Care Inc.Analyte monitoring system and methods for managing power and noise
EP3001194B1 (en)2009-08-312019-04-17Abbott Diabetes Care, Inc.Medical devices and methods
WO2011041531A1 (en)2009-09-302011-04-07Abbott Diabetes Care Inc.Interconnect for on-body analyte monitoring device
US9035744B2 (en)*2009-10-012015-05-19Blackberry LimitedMethod and apparatus for monitoring and controlling a medical device using a wireless mobile communication device
EP2315146B1 (en)2009-10-012015-08-12BlackBerry LimitedMethod and apparatus for monitoring and controlling a medical device using a wireless mobile communication device
TWI517050B (en)2009-11-042016-01-11普羅托斯數位健康公司System for supply chain management
GB2475091A (en)*2009-11-062011-05-11Rahul KardamPortable multifunctional biometric monitoring system
UA109424C2 (en)2009-12-022015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
US20110151571A1 (en)*2009-12-232011-06-23Roche Diagnostics Operations, Inc.Memory apparatus for multiuse analyte test element systems, and kits, systems, combinations and methods relating to same
US8803688B2 (en)*2010-01-072014-08-12Lisa HalffSystem and method responsive to an event detected at a glucose monitoring device
US20110163880A1 (en)*2010-01-072011-07-07Lisa HalffSystem and method responsive to an alarm event detected at an insulin delivery device
BR112012019212A2 (en)2010-02-012017-06-13Proteus Digital Health Inc data collection system
JP2011180014A (en)*2010-03-022011-09-15Maruto Seisakusho:KkMeasuring instrument for unit water quantity of ready-mixed concrete
JP5470132B2 (en)*2010-03-302014-04-16テルモ株式会社 Blood sugar level management device and blood sugar level management method
JP2011206486A (en)*2010-03-302011-10-20Terumo CorpApparatus for measuring blood glucose and blood glucose level controlling system
RU2012146350A (en)*2010-03-312014-05-10Энимас Корпорейшн METHOD AND SYSTEM OF DISPLAYING DATA OF ANALYTICAL SENSOR
WO2011127252A2 (en)2010-04-072011-10-13Proteus Biomedical, Inc.Miniature ingestible device
US10238362B2 (en)2010-04-262019-03-26Gary And Mary West Health InstituteIntegrated wearable device for detection of fetal heart rate and material uterine contractions with wireless communication capability
CN102236919A (en)*2010-04-292011-11-09国基电子(上海)有限公司Hand-held device and method for recording abnormal status of vehicle thereof
TWI557672B (en)2010-05-192016-11-11波提亞斯數位康健公司Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
WO2011149857A1 (en)2010-05-242011-12-01Abbott Diabetes Care Inc.Method and system for updating a medical device
US8635046B2 (en)2010-06-232014-01-21Abbott Diabetes Care Inc.Method and system for evaluating analyte sensor response characteristics
US8206340B2 (en)2010-08-182012-06-26Thuban, Inc.Integrated glucose monitor and insulin injection pen with automatic emergency notification
US11213226B2 (en)2010-10-072022-01-04Abbott Diabetes Care Inc.Analyte monitoring devices and methods
US9526920B2 (en)2010-10-122016-12-27Smith & Nephew, Inc.Medical device
US9717412B2 (en)2010-11-052017-08-01Gary And Mary West Health InstituteWireless fetal monitoring system
JP2014504902A (en)2010-11-222014-02-27プロテウス デジタル ヘルス, インコーポレイテッド Ingestible device with medicinal product
US9262586B2 (en)2010-12-202016-02-16Roche Diabetes Care, Inc.Representation of large, variable size data sets on small displays
WO2012092197A2 (en)2010-12-272012-07-05Medtronic, Inc.Application limitations for a medical communication module and host device
US20130334300A1 (en)*2011-01-032013-12-19Curt EvansText-synchronized media utilization and manipulation based on an embedded barcode
WO2012108936A1 (en)*2011-02-112012-08-16Abbott Diabetes Care Inc.Data synchronization between two or more analyte detecting devices in a database
US9913599B2 (en)2011-02-112018-03-13Abbott Diabetes Care Inc.Software applications residing on handheld analyte determining devices
US20140081662A1 (en)*2011-02-112014-03-20Abbott Diabetes Care Inc.Sensor-Based Informatics Telemedicine Disease Management Solution
WO2012108939A1 (en)2011-02-112012-08-16Abbott Diabetes Care Inc.Feedback from cloud or hcp to payer or patient via meter or cell phone
CN107019515B (en)2011-02-282021-02-26雅培糖尿病护理公司Method of displaying sensor readings and analyte monitoring device and method of operating the same
US10136845B2 (en)2011-02-282018-11-27Abbott Diabetes Care Inc.Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
WO2012125425A2 (en)2011-03-112012-09-20Proteus Biomedical, Inc.Wearable personal body associated device with various physical configurations
JP5543399B2 (en)2011-04-122014-07-09日本光電工業株式会社 Biological information monitoring device
US8774837B2 (en)2011-04-302014-07-08John Anthony WrightMethods, systems and apparatuses of emergency vehicle locating and the disruption thereof
US9075900B2 (en)*2011-05-182015-07-07Exco IntouchSystems, methods and computer program products for providing compliant delivery of content, applications and/or solutions
JP2012247338A (en)*2011-05-302012-12-13Gunze LtdMeasurement display device
US9974472B2 (en)2011-06-162018-05-22Abbott Diabetes Care Inc.Temperature-compensated analyte monitoring devices, systems, and methods thereof
US9756874B2 (en)2011-07-112017-09-12Proteus Digital Health, Inc.Masticable ingestible product and communication system therefor
WO2015112603A1 (en)2014-01-212015-07-30Proteus Digital Health, Inc.Masticable ingestible product and communication system therefor
PH12014500174A1 (en)2011-07-212024-02-12Proteus Digital Health IncMobile communication device, system, and method
CN106326651A (en)2011-08-262017-01-11弗吉尼亚大学专利基金会Method and system for adaptive advisory control of diabetes
US9247004B2 (en)*2011-10-252016-01-26Vital Connect, Inc.System and method for reliable and scalable health monitoring
WO2013063370A1 (en)*2011-10-262013-05-02ERP Systems Corp.Two way short message service (sms)-enabled blood glucose meter and related communications systems and methods
WO2013061296A2 (en)2011-10-282013-05-02Debiotech S.A.Mobile virtualization platform for the remote control of a medical device
US9622691B2 (en)2011-10-312017-04-18Abbott Diabetes Care Inc.Model based variable risk false glucose threshold alarm prevention mechanism
US9069536B2 (en)2011-10-312015-06-30Abbott Diabetes Care Inc.Electronic devices having integrated reset systems and methods thereof
WO2013070794A2 (en)2011-11-072013-05-16Abbott Diabetes Care Inc.Analyte monitoring device and methods
US9235683B2 (en)2011-11-092016-01-12Proteus Digital Health, Inc.Apparatus, system, and method for managing adherence to a regimen
US8710993B2 (en)2011-11-232014-04-29Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9317656B2 (en)2011-11-232016-04-19Abbott Diabetes Care Inc.Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US10276054B2 (en)2011-11-292019-04-30Eresearchtechnology, Inc.Methods and systems for data analysis
KR101252654B1 (en)*2011-12-092013-05-14에이알비전 (주)Health care method for self-diagnosis
WO2013098658A1 (en)*2011-12-282013-07-04Turkcell Teknoloji Arastirma Ve Gelistirme Anonim SirketiA remote patient management device and method
US8976021B2 (en)2011-12-282015-03-10Turkcell Teknoloji Arastirma Ve Gelistirme Anonim SirketiRemote patient management device and method
KR101323683B1 (en)*2012-01-032013-10-30주식회사 필로시스Automatic Processing Method of Information for Purchasing Teststrip
US9335910B2 (en)2012-04-232016-05-10Tandem Diabetes Care, Inc.System and method for reduction of inadvertent activation of medical device during manipulation
US9180242B2 (en)2012-05-172015-11-10Tandem Diabetes Care, Inc.Methods and devices for multiple fluid transfer
EP2852333B1 (en)2012-05-222021-12-15Smith & Nephew plcApparatuses for wound therapy
US20130318149A1 (en)*2012-05-232013-11-28National Yang-Ming UniversityCloud-based activity programming
US10453573B2 (en)2012-06-052019-10-22Dexcom, Inc.Dynamic report building
US9238100B2 (en)2012-06-072016-01-19Tandem Diabetes Care, Inc.Device and method for training users of ambulatory medical devices
US9715327B2 (en)2012-06-072017-07-25Tandem Diabetes Care, Inc.Preventing inadvertent changes in ambulatory medical devices
US20140012118A1 (en)*2012-07-092014-01-09Dexcom, Inc.Systems and methods for leveraging smartphone features in continuous glucose monitoring
CN104641375B (en)*2012-07-092018-01-02生物技术公司 Secure communication between medical devices and their remote devices
EP2874886B1 (en)2012-07-232023-12-20Otsuka Pharmaceutical Co., Ltd.Techniques for manufacturing ingestible event markers comprising an ingestible component
US10132793B2 (en)2012-08-302018-11-20Abbott Diabetes Care Inc.Dropout detection in continuous analyte monitoring data during data excursions
US9968306B2 (en)2012-09-172018-05-15Abbott Diabetes Care Inc.Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
WO2014052136A1 (en)2012-09-262014-04-03Abbott Diabetes Care Inc.Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US10318915B2 (en)2012-09-262019-06-11Thuban, Inc.Healthcare system for recording and monitoring transactions of system participants
AU2013331417B2 (en)2012-10-182016-06-02Proteus Digital Health, Inc.Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9363010B2 (en)*2012-12-032016-06-07Samsung Electronics Co., Ltd.Mobile terminal and method of controlling function of the mobile terminal
US9642563B2 (en)2012-12-182017-05-09Crawford Capital Investments, LlcGlucose monitoring device in a protective smartphone case
US9801541B2 (en)*2012-12-312017-10-31Dexcom, Inc.Remote monitoring of analyte measurements
US9730621B2 (en)*2012-12-312017-08-15Dexcom, Inc.Remote monitoring of analyte measurements
US11149123B2 (en)2013-01-292021-10-19Otsuka Pharmaceutical Co., Ltd.Highly-swellable polymeric films and compositions comprising the same
KR101466690B1 (en)*2013-02-192014-11-28전자부품연구원Glucosuria Data Gathering Module attachable to Mobile Device and Glucosuria Data Gathering Method thereof
US9357961B2 (en)2013-02-222016-06-07Thuban, Inc.Device for enabling patient self testing and treatment self- administration and system using the device for managing the patient's health care
EP2770453A1 (en)*2013-02-222014-08-27Samsung Electronics Co., Ltd.Method and system for implementing alarms for medical device through mobile device
EP2770452A1 (en)*2013-02-222014-08-27Samsung Electronics Co., Ltd.Method and system for transmitting result of examination of specimen from medical device to destination through mobile device
US10404784B2 (en)*2013-02-222019-09-03Samsung Electronics Co., Ltd.Method and system for transmitting result of examination of specimen from medical device to destination
US9737649B2 (en)2013-03-142017-08-22Smith & Nephew, Inc.Systems and methods for applying reduced pressure therapy
JP2016517318A (en)2013-03-142016-06-16スミス アンド ネフュー インコーポレーテッド System and method for administering decompression therapy
US9173998B2 (en)2013-03-142015-11-03Tandem Diabetes Care, Inc.System and method for detecting occlusions in an infusion pump
WO2014144738A1 (en)2013-03-152014-09-18Proteus Digital Health, Inc.Metal detector apparatus, system, and method
US10076285B2 (en)2013-03-152018-09-18Abbott Diabetes Care Inc.Sensor fault detection using analyte sensor data pattern comparison
US9474475B1 (en)2013-03-152016-10-25Abbott Diabetes Care Inc.Multi-rate analyte sensor data collection with sample rate configurable signal processing
JP6498177B2 (en)2013-03-152019-04-10プロテウス デジタル ヘルス, インコーポレイテッド Identity authentication system and method
US10433773B1 (en)2013-03-152019-10-08Abbott Diabetes Care Inc.Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US10453566B2 (en)*2013-04-262019-10-22Roche Diabetes Care, Inc.Method for reconciling medical data captured on one device with a structured test administered on another device
AU2014260023B2 (en)2013-04-302018-12-06Abbott Diabetes Care Inc.Systems, devices, and methods for energy efficient electrical device activation
EP3005281A4 (en)2013-06-042017-06-28Proteus Digital Health, Inc.System, apparatus and methods for data collection and assessing outcomes
US10289280B2 (en)2013-06-072019-05-14Medtronic, Inc.Determining vertical axis scale for implantable fluid delivery system
US9796576B2 (en)2013-08-302017-10-24Proteus Digital Health, Inc.Container with electronically controlled interlock
WO2015035304A1 (en)2013-09-062015-03-12Tandem Diabetes Care, Inc.System and method for mitigating risk in automated medicament dosing
CA2965941C (en)2013-09-202020-01-28Proteus Digital Health, Inc.Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
WO2015044722A1 (en)2013-09-242015-04-02Proteus Digital Health, Inc.Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en)2013-11-042018-09-25Proteus Digital Health, Inc.Social media networking based on physiologic information
JP2017502306A (en)*2014-01-102017-01-19アセンシア・ディアベティス・ケア・ホールディングス・アーゲー Method and apparatus for graphically displaying blood glucose fluctuations
WO2015112870A1 (en)2014-01-252015-07-30Cloudpin Inc.Systems and methods for location-based content sharing using unique identifiers
US9486580B2 (en)2014-01-312016-11-08Aseko, Inc.Insulin management
US9233204B2 (en)2014-01-312016-01-12Aseko, Inc.Insulin management
US20170185748A1 (en)2014-03-302017-06-29Abbott Diabetes Care Inc.Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
CN106470717B (en)2014-06-032020-09-11安姆根有限公司 Drug delivery system and method of use
US12133789B2 (en)2014-07-312024-11-05Smith & Nephew, Inc.Reduced pressure therapy apparatus construction and control
CA2897745A1 (en)*2014-07-312016-01-31Kian MahbubianMethod, system and apparatus for controlling dispensing of medication
US9592335B2 (en)*2014-10-202017-03-14Medtronic Minimed, Inc.Insulin pump data acquisition device
US9841014B2 (en)*2014-10-202017-12-12Medtronic Minimed, Inc.Insulin pump data acquisition device and system
US10285591B2 (en)2014-10-222019-05-14Dexcom, Inc.User interfaces for continuous glucose monitoring
US11081226B2 (en)2014-10-272021-08-03Aseko, Inc.Method and controller for administering recommended insulin dosages to a patient
CA2927335C (en)2014-10-272023-05-02Aseko, Inc.Subcutaneous outpatient management
KR20160066076A (en)*2014-11-302016-06-10(주)씨어스테크놀로지Healthcare system and controlling method thereof
US10086208B2 (en)2015-02-272018-10-02Medtronic, Inc.Systems, apparatus, methods and computer-readable storage media facilitating authorized telemetry with an implantable device
EP3101571B1 (en)*2015-06-032018-05-02Roche Diabetes Care GmbHMeasurement system for measuring the concentration of an analyte with a subcutaneous analyte sensor
DE202016009220U1 (en)2015-07-102024-07-09Abbott Diabetes Care, Inc. Device and system for dynamic glucose profile response to physiological parameters
US11051543B2 (en)2015-07-212021-07-06Otsuka Pharmaceutical Co. Ltd.Alginate on adhesive bilayer laminate film
WO2017031440A1 (en)2015-08-202017-02-23Aseko, Inc.Diabetes management therapy advisor
US11315681B2 (en)2015-10-072022-04-26Smith & Nephew, Inc.Reduced pressure therapy device operation and authorization monitoring
EP3155958B1 (en)2015-10-162021-11-17Roche Diabetes Care GmbHA method for operating a system and a system
CN109069713A (en)2016-05-132018-12-21史密夫和内修有限公司Automatic wound in negative pressure wound treating system couples detection
KR20210018961A (en)2016-07-222021-02-18프로테우스 디지털 헬스, 인코포레이티드Electromagnetic sensing and detection of ingestible event markers
AU2017335762B2 (en)2016-09-272022-03-17Bigfoot Biomedical, Inc.Medicine injection and disease management systems, devices, and methods
US12263294B2 (en)2016-09-282025-04-01T.J.Smith And Nephew, LimitedSystems and methods for operating negative pressure wound therapy devices
WO2018064077A2 (en)2016-09-292018-04-05Smith & Nephew, Inc.Construction and protection of components in negative pressure wound therapy systems
CN109963499B (en)2016-10-262022-02-25大冢制药株式会社Method for manufacturing capsules with ingestible event markers
USD836769S1 (en)2016-12-122018-12-25Bigfoot Biomedical, Inc.Insulin delivery controller
EP3500161A4 (en)2016-12-122020-01-08Bigfoot Biomedical, Inc. ALARMS AND WARNINGS FOR MEDICINE DELIVERY DEVICES AND RELATED SYSTEMS AND METHODS
US11071478B2 (en)2017-01-232021-07-27Abbott Diabetes Care Inc.Systems, devices and methods for analyte sensor insertion
WO2018165049A1 (en)2017-03-072018-09-13Smith & Nephew, Inc.Reduced pressure therapy systems and methods including an antenna
WO2018175489A1 (en)2017-03-212018-09-27Abbott Diabetes Care Inc.Methods, devices and system for providing diabetic condition diagnosis and therapy
CN117373636A (en)*2017-05-082024-01-09梅西莫股份有限公司System for pairing a medical system with a network controller using an adapter
USD839294S1 (en)2017-06-162019-01-29Bigfoot Biomedical, Inc.Display screen with graphical user interface for closed-loop medication delivery
WO2019014141A1 (en)2017-07-102019-01-17Smith & Nephew, Inc.Systems and methods for directly interacting with communications module of wound therapy apparatus
EP3651647A1 (en)2017-07-132020-05-20Bigfoot Biomedical, Inc.Multi-scale display of blood glucose information
US11083852B2 (en)2017-12-122021-08-10Bigfoot Biomedical, Inc.Insulin injection assistance systems, methods, and devices
US10987464B2 (en)2017-12-122021-04-27Bigfoot Biomedical, Inc.Pen cap for insulin injection pens and associated methods and systems
US11116899B2 (en)2017-12-122021-09-14Bigfoot Biomedical, Inc.User interface for diabetes management systems and devices
IL275301B2 (en)2017-12-122024-01-01Bigfoot Biomedical IncTherapy assist information and/or tracking device and related methods and systems
US11464459B2 (en)*2017-12-122022-10-11Bigfoot Biomedical, Inc.User interface for diabetes management systems including flash glucose monitor
US11197964B2 (en)2017-12-122021-12-14Bigfoot Biomedical, Inc.Pen cap for medication injection pen having temperature sensor
US11077243B2 (en)2017-12-122021-08-03Bigfoot Biomedical, Inc.Devices, systems, and methods for estimating active medication from injections
US11779217B2 (en)2018-05-312023-10-10Inspire Medical Systems, Inc.System and method for collecting and displaying data acquired from an implantable therapy device using a consumer electronic device
FR3083075B1 (en)*2018-06-282023-01-13Mirambeauappcare METHOD FOR MANAGING OR ASSISTING IN CONTROLLING A PHYSIOLOGICAL PARAMETER OF AN INDIVIDUAL, IN PARTICULAR GLYCEMIA LEVELS
EP3591662A1 (en)*2018-07-052020-01-08Advanced Microfluidics SAMedical device and secure control system
KR102200139B1 (en)*2018-08-072021-01-08주식회사 아이센스Apparatus for controlling operation of CGMS
US12205699B1 (en)2018-10-302025-01-21Bigfoot Biomedical, Inc.Method of pairing therapy devices using shared secrets, and related systems, methods and devices
GB201820668D0 (en)2018-12-192019-01-30Smith & Nephew IncSystems and methods for delivering prescribed wound therapy
GB201911693D0 (en)2019-08-152019-10-02Smith & NephewSystems and methods for monitoring essential performance of wound therapy
US20220375599A1 (en)*2019-11-132022-11-24West Pharmaceutical Services, Inc.Systems and methods for medical device usage managment
KR102303553B1 (en)*2019-11-212021-09-23주식회사 아이센스Sensor apparatus for continuous glucose monitoring
CA3188510A1 (en)2020-08-312022-03-03Vivek S. RAOSystems, devices, and methods for analyte sensor insertion

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5338157B1 (en)*1992-09-091999-11-02Sims Deltec IncSystems and methods for communicating with ambulat
DE2758467C2 (en)*1977-12-281985-04-04Siemens AG, 1000 Berlin und 8000 München Device for the pre-programmable infusion of liquids
DE2758368C2 (en)*1977-12-281985-10-17Siemens AG, 1000 Berlin und 8000 München Device for the pre-programmable infusion of liquids
US4373527B1 (en)*1979-04-271995-06-27Univ Johns HopkinsImplantable programmable medication infusion system
US4494950A (en)*1982-01-191985-01-22The Johns Hopkins UniversityPlural module medication delivery system
US4685903A (en)1984-01-061987-08-11Pacesetter Infusion, Ltd.External infusion pump apparatus
US4562751A (en)1984-01-061986-01-07Nason Clyde KSolenoid drive apparatus for an external infusion pump
US4678408A (en)1984-01-061987-07-07Pacesetter Infusion, Ltd.Solenoid drive apparatus for an external infusion pump
US5100380A (en)*1984-02-081992-03-31Abbott LaboratoriesRemotely programmable infusion system
CA1254091A (en)*1984-09-281989-05-16Vladimir FeingoldImplantable medication infusion system
US4731726A (en)*1986-05-191988-03-15Healthware CorporationPatient-operated glucose monitor and diabetes management system
US4809697A (en)*1987-10-141989-03-07Siemens-Pacesetter, Inc.Interactive programming and diagnostic system for use with implantable pacemaker
US5050612A (en)*1989-09-121991-09-24Matsumura Kenneth NDevice for computer-assisted monitoring of the body
US5918603A (en)*1994-05-231999-07-06Health Hero Network, Inc.Method for treating medical conditions using a microprocessor-based video game
US6168563B1 (en)*1992-11-172001-01-02Health Hero Network, Inc.Remote health monitoring and maintenance system
US5307263A (en)*1992-11-171994-04-26Raya Systems, Inc.Modular microprocessor-based health monitoring system
US5899855A (en)*1992-11-171999-05-04Health Hero Network, Inc.Modular microprocessor-based health monitoring system
US5913310A (en)*1994-05-231999-06-22Health Hero Network, Inc.Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game
US5417222A (en)*1994-01-211995-05-23Hewlett-Packard CompanyPatient monitoring system
US5536249A (en)*1994-03-091996-07-16Visionary Medical Products, Inc.Pen-type injector with a microprocessor and blood characteristic monitor
US5391250A (en)1994-03-151995-02-21Minimed Inc.Method of fabricating thin film sensors
US5390671A (en)*1994-03-151995-02-21Minimed Inc.Transcutaneous sensor insertion set
DE4415896A1 (en)*1994-05-051995-11-09Boehringer Mannheim Gmbh Analysis system for monitoring the concentration of an analyte in the blood of a patient
US5582593A (en)*1994-07-211996-12-10Hultman; Barry W.Ambulatory medication delivery system
US5687734A (en)*1994-10-201997-11-18Hewlett-Packard CompanyFlexible patient monitoring system featuring a multiport transmitter
US5573506A (en)*1994-11-251996-11-12Block Medical, Inc.Remotely programmable infusion system
US5568806A (en)1995-02-161996-10-29Minimed Inc.Transcutaneous sensor insertion set
US5586553A (en)1995-02-161996-12-24Minimed Inc.Transcutaneous sensor insertion set
US5713856A (en)*1995-03-131998-02-03Alaris Medical Systems, Inc.Modular patient care system
FI118509B (en)*1996-02-122007-12-14Nokia Oyj Method and apparatus for predicting glucose levels in the blood of a patient
JP2849809B2 (en)*1996-04-231999-01-27株式会社京都第一科学 A device that measures body fluid components and stores and manages the test data.
FI114182B (en)*1996-06-062004-08-31Nokia Corp Method of utilizing services offered by a telecommunications network, a telecommunications system and its terminal
US5885245A (en)*1996-08-021999-03-23Sabratek CorporationMedical apparatus with remote virtual input device
FI104876B (en)*1996-11-122000-04-14Nokia Mobile Phones Ltd System and method for retrieving data from a database
US5961451A (en)*1997-04-071999-10-05Motorola, Inc.Noninvasive apparatus having a retaining member to retain a removable biosensor
JPH10328170A (en)*1997-05-291998-12-15Koji AkaiBlood sugar monitoring system
FI107080B (en)*1997-10-272001-05-31Nokia Mobile Phones Ltd measuring device
US6134461A (en)1998-03-042000-10-17E. Heller & CompanyElectrochemical analyte
US7647237B2 (en)*1998-04-292010-01-12Minimed, Inc.Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like
US6175752B1 (en)*1998-04-302001-01-16Therasense, Inc.Analyte monitoring device and methods of use
US6558320B1 (en)*2000-01-202003-05-06Medtronic Minimed, Inc.Handheld personal data assistant (PDA) with a medical device and method of using the same
US6554798B1 (en)1998-08-182003-04-29Medtronic Minimed, Inc.External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6248067B1 (en)*1999-02-052001-06-19Minimed Inc.Analyte sensor and holter-type monitor system and method of using the same
CA2345043C (en)1998-10-082009-08-11Minimed, Inc.Telemetered characteristic monitor system
US6478736B1 (en)*1999-10-082002-11-12Healthetech, Inc.Integrated calorie management system
US6602191B2 (en)*1999-12-172003-08-05Q-Tec Systems LlpMethod and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
US6513532B2 (en)*2000-01-192003-02-04Healthetech, Inc.Diet and activity-monitoring device
US6577899B2 (en)*2000-01-212003-06-10Medtronic Minimed, Inc.Microprocessor controlled ambulatory medical apparatus with hand held communication device
US6699188B2 (en)*2000-06-222004-03-02Guidance Interactive TechnologiesInteractive reward devices and methods
EP1379167A1 (en)*2001-04-062004-01-14Medic4all Inc.A physiological monitoring system for a computational device of a human subject
US20020193979A1 (en)*2001-05-172002-12-19Paterson Thomas S.Apparatus and method for validating a computer model
JP2002368907A (en)*2001-06-082002-12-20Arkray IncData transfer device, data transmission method, measurement device, data processing unit, and program
EP1403795A4 (en)*2001-06-222007-08-01Arkray Inc DATA TRANSMISSION SYSTEM
JP2003032338A (en)*2001-07-132003-01-31Calsonic Kansei CorpBluetooth pack and bluetooth portable terminal
US20030065536A1 (en)*2001-08-132003-04-03Hansen Henrik EgesborgPortable device and method of communicating medical data information
JP2004538078A (en)*2001-08-202004-12-24インバネス・メディカル・リミテッド Wireless diabetes management device and method of using wireless diabetes management device
US7399277B2 (en)*2001-12-272008-07-15Medtronic Minimed, Inc.System for monitoring physiological characteristics
CA2483283A1 (en)*2002-04-222003-11-20Medtronic, Inc.Seamless communication between an implantable medical device and a remote system
KR100472092B1 (en)*2002-05-142005-03-08주식회사 헬스피아A blood sugar test device using a wireless phone and a method to transmit the blood sugar level to internet server
US7920827B2 (en)*2002-06-262011-04-05Nokia CorporationApparatus and method for facilitating physical browsing on wireless devices using radio frequency identification
US6817979B2 (en)*2002-06-282004-11-16Nokia CorporationSystem and method for interacting with a user's virtual physiological model via a mobile terminal
GB2393356B (en)*2002-09-182006-02-01E San LtdTelemedicine system
FR2851350B1 (en)*2003-02-142005-05-20Baracoda BLUETOOTH AUTONOMOUS ADAPTER BOX FOR COMPUTER PERIPHERAL, USB BLUETOOTH ADAPTER MASTER AND COMMUNICATION SYSTEM
AU2004224345B2 (en)*2003-03-212010-02-18Welch Allyn, Inc.Personal status physiologic monitor system and architecture and related monitoring methods
WO2004090661A2 (en)*2003-04-082004-10-21Medic4All A.GA portable wireless gateway for remote medical examination
JP2005050253A (en)*2003-07-312005-02-24Integrated Business:KkInformation collecting system by mobile terminal
US7591801B2 (en)*2004-02-262009-09-22Dexcom, Inc.Integrated delivery device for continuous glucose sensor
JP4273036B2 (en)*2004-05-122009-06-03中 奥村 Medication support program, medication support device, recording medium recording medication support program, and medication support system
US20060009684A1 (en)*2004-07-072006-01-12Steven KimSystem for monitoring compliance to a healthcare regiment of testing
US7344500B2 (en)*2004-07-272008-03-18Medtronic Minimed, Inc.Sensing system with auxiliary display
WO2006037802A2 (en)*2004-10-072006-04-13Novo Nordisk A/SMethod and system for self- management of a disease
EP1871219A4 (en)*2005-02-222011-06-01Health Smart LtdMethods and systems for physiological and psycho-physiological monitoring and uses thereof
CA2633617A1 (en)*2005-04-112006-10-19F. Hoffmann-La Roche AgWeb-enabled portable medical device
EP1722310A1 (en)*2005-04-122006-11-15Roche Diagnostics GmbHMedical software download to mobile phone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references ofWO2008064053A2*

Also Published As

Publication numberPublication date
JP5259611B2 (en)2013-08-07
JP5797224B2 (en)2015-10-21
WO2008064053A3 (en)2008-09-25
WO2008064053A2 (en)2008-05-29
CA2667386A1 (en)2008-05-29
JP2010510586A (en)2010-04-02
EP2386971A3 (en)2012-10-24
US20080119705A1 (en)2008-05-22
JP2013176579A (en)2013-09-09
WO2008064053A9 (en)2008-08-07
CA2667386C (en)2015-04-14
EP2386971A2 (en)2011-11-16

Similar Documents

PublicationPublication DateTitle
CA2667386C (en)Systems and methods for diabetes management using consumer electronic devices
US20200168328A1 (en)System for collecting patient information for diabetes management
US20120227737A1 (en)Analyte sensor and method of using the same
US20070093786A1 (en)Watch controller for a medical device
JP2009504322A (en) Handheld controller device for infusion pump
JP2009504323A (en) Controller device for infusion pump
US20110124996A1 (en)Diabetes health management systems and methods
US20110098674A1 (en)Method and System for Programming an Infusion Device
US20110098638A1 (en)Sensor-Augmented Medication Infusion System
US20110098637A1 (en)Method and System for Configuring an Insulin Infusion Device
US20080228057A1 (en)Method and system for controlling data information between two portable apparatuses
CN104781820A (en) Systems and methods for utilizing smartphone features in continuous glucose monitoring
AU2002354523A1 (en)Method and system for controlling data information between two portable medical apparatuses
WO2003005891A1 (en)Method and system for controlling data information between two portable medical apparatuses
KR20230128325A (en) Medication Delivery System with Graphical User Interface
JP2025527145A (en) Systems and methods for diabetes management
BonaldoEmpowering people with type 1 diabetes in physical activity: an app to support decision-making on physical activity and insulin therapy
HK1136047A (en)System and method for collecting patient information from which diabetes therapy may be determined

Legal Events

DateCodeTitleDescription
PUAIPublic reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text:ORIGINAL CODE: 0009012

17PRequest for examination filed

Effective date:20090518

AKDesignated contracting states

Kind code of ref document:A2

Designated state(s):AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RIN1Information on inventor provided before grant (corrected)

Inventor name:NARANG, AJIT

Inventor name:LIN, JACK

Inventor name:ISTOC, EMIL

Inventor name:PATEL, HIMANSHU

17QFirst examination report despatched

Effective date:20090827

DAXRequest for extension of the european patent (deleted)
REGReference to a national code

Ref country code:DE

Ref legal event code:R003

STAAInformation on the status of an ep patent application or granted ep patent

Free format text:STATUS: THE APPLICATION HAS BEEN REFUSED

18RApplication refused

Effective date:20140321


[8]ページ先頭

©2009-2025 Movatter.jp